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Early g-aminobutyric acid mediated (GABAergic) synaptic trans-
mission and correlated neuronal activity are fundamental to
network formation; however, their regulation during early postnatal
development is poorly understood. Nitric oxide (NO) is an important
retrograde messenger at glutamatergic synapses, and it was
recently shown to play an important role also at GABAergic
synapses in the adult brain. The subcellular localization and
network effect of this signaling pathway during early development
are so far unexplored, but its disruption at this early age is known
to lead to profound morphological and functional alterations. Here,
we provide functional evidence—using whole-cell recording—that
NO signaling modulates not only glutamatergic but also GABAergic
synaptic transmission in the mouse hippocampus during the early
postnatal period. We identiﬁed the precise subcellular localization
of key elements of the underlying molecular cascade using
immunohistochemistry at the light—and electron microscopic
levels. As predicted by these morpho-functional data, multineuron
calcium imaging in acute slices revealed that this NO-signaling
machinery is involved also in the control of synchronous network
activity patterns. We suggest that the retrograde NO-signaling
system is ideally suited to fulﬁll a general presynaptic regulatory
role and may effectively ﬁne-tune network activity during early
postnatal development, while GABAergic transmission is still
depolarizing.
Keywords: GABAergic synapse, hippocampus, nNOS, retrograde signaling,
synchronous activity
Introduction
Recruitment of c-aminobutyric acid mediated (GABAergic)
inhibition shapes synchronous population events in the adult
brain. However, during the early postnatal period, GABAergic
synaptic transmission exerts a complex depolarizing (excit-
atory/shunting inhibitory) effect, which is shifted to hyper-
polarizing (inhibitory) only during the second postnatal week
(Ben-Ari et al. 2007). Hence, the role of GABA signaling during
the early postnatal period is associated with the generation of
the ﬁrst synapse-driven synchronous network activity pat-
terns—giant depolarizing potentials in vitro (Ben-Ari et al.
2007; Crepel et al. 2007) or synchronous burst activity in vivo
(Sipila et al. 2006). GABAergic synaptic transmission and
synchronous activity of cell assemblies are fundamental to
the formation of functional networks (Ge et al. 2006;
Mohajerani and Cherubini 2006; Akerman and Cline 2007;
Cancedda et al. 2007; Wang and Kriegstein 2008). However, the
regulation of these events is poorly understood.
The blockade of nitric oxide (NO) signaling during de-
velopment leads to disturbances in dendrite morphology and to
a reduction in synapse numbers (Sa ´ nchez-Islas and Leo ´ n-Olea
2004; Morales-Medina et al. 2007). These data reﬂect the
developmental importance of the NO pathway and raise the
question whether it manifests at the synaptic or networks
levels or both and whether GABAergic transmission that
normally shapes network patterns is also under the control of
retrograde NO signaling during early postnatal development.
NO is an effective modulator of synaptic transmission in the
adult hippocampus (Burette et al. 2002; Bon and Garthwaite
2003; Makara et al. 2007; Szabadits et al. 2007). The NO-
sensitive guanylyl cyclase (NOsGC) that contains an a and a b
subunit, is the NO receptor in the brain (Koesling et al. 2004),
and the only cGMP-producing enzyme in hippocampal neurons
(Teunissen et al. 2001). Accordingly, NO induces the pro-
duction of the second messenger cGMP, which may alter the
probability of vesicular release depending on the type of
terminal and brain region (Garthwaite 2008).
In low-resolution immunocytochemical and in situ hybrid-
ization studies, the rodent hippocampus was found to express
neuronal nitric oxide synthase (nNOS) and NOsGC already
during the early postnatal days (Giuili et al. 1994; Chung et al.
2004). However, the cellular and subcellular localization of the
elements of this signaling pathway and their effects on synaptic
transmission and network activity during development
remained unexplored.
Here, we showed that nNOS was present in pyramidal cells in
the postsynaptic active zones of both GABAergic and glutama-
tergic synapses already during the early postnatal period in
mouse hippocampus. GABAergic terminals contained the a1a n d
b1 subunits of NOsGC, and a NO donor was able to induce cGMP
production in these terminals, which effect was abolished by
NOsGC inhibitors. In postnatal acute slices, NO was found to
decrease GABAergic and glutamatergic postsynaptic currents
(PSCs), whereas multineuron calcium imaging revealed that
inhibition or stimulation of NO signaling enhanced or sup-
pressed synchronous network events, respectively. These results
provide the ﬁrst evidence that the synapse-speciﬁc NO signaling
machinery is present during the early postnatal days. By the
reduction of GABAergic and glutamatergic synaptic transmission,
it is able to ﬁne-tune the ﬁrst synaptic events and thereby affect
synchronous network activity in the hippocampus at a time
when GABAergic transmission is still depolarizing.
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Animal Perfusions
All experiments were performed in accordance with the Institutional
Ethical Codex and the Hungarian Act of Animal Care and Experimen-
tation guidelines, which are in concert with the European Communities
Council Directive of 24 November 1986 (86/609/EEC). Twenty-two
male C57BL/6 mice between the ages of 4 days (P4) and 14 days (P14)
in addition to 2 males and 1 female 6 days old (P6) nNOS knockout
(–/–) mice were deeply anesthetized with isoﬂurane, followed by an
intraperitoneal injection of 0.1--0.2 mL of an anesthetic mixture
(containing 0.83% ketamine, 0.17% xylazin hydrochloride, 0.083%
promethazinium chloride, 0.00083% benzethonium chloride, and
0.00067% hydrochinonum). Animals were perfused transcardially
with 0.9% NaCl solution followed by a ﬁxative. The perfusions were
performed differentially depending on the type of immunocytochem-
istry that followed. In the preembedding experiments for localizing
nNOS, the ﬁxative contained 1% freshly depolymerized paraformal-
dehyde in 0.1 M phosphate buffer (PB), pH 7.4, and the animals were
perfused for 60 min. In the preembedding experiments for localizing
NOsGC subunits, the ﬁxative contained 4% freshly depolymerized
paraformaldehyde in 0.1 M PB, pH 7.4, and the animals were perfused
for 40 min. All ﬁxative solutions were followed by perfusion with 0.1
M PB for 10 min, the brains were removed from the skull and were not
postﬁxed. Blocks containing the dorsal hippocampi were dissected
and coronal sections were prepared on a Vibratome (VT1000S; Leica)
at 70--100 lm, followed by washing in 0.1 M PB. Then, they were
incubated in 10% and 30% sucrose in PB for cryoprotection, and
freeze thawed over liquid nitrogen. After repeated washes in 0.1 M PB,
the sections were processed for immunostaining.
Slice Preparation
For slice preparation, 5 to 8-day-old (P5--P8) animals were decapitated,
the brains were removed and placed into ice-cold cutting solution
containing the following (in mM): 252 sucrose, 2.5 KCl, 1.25 NaH2PO4,
5 MgCl2, 0.5 CaCl2, 26 NaHCO3, and 10 glucose. The cutting solution
had been bubbled with 95%O2/5%CO2 (carbogen gas). Coronal or
horizontal hippocampal slices were prepared on a Vibratome
(VT1200S; Leica). We prepared 300 lm thick slices for cGMP
immunhistochemistry and 450 lm thick slices for the in vitro
electrophysiology and multineuron calcium imaging experiments.
Slices were incubated for 1 h in artiﬁcial cerebrospinal ﬂuid (ACSF; in
mM: 126 NaCl, 3.5 KCl, 1.25 NaH2PO4, 1.3 MgCl2, 2 CaCl2, 26 NaHCO3,
and 10 glucose) equilibrated with carbogen gas, at room temperature,
in interface conditions before the experiments. For the electrophys-
iological and multineuron calcium imaging experiments, slices were
transferred to submerged type dual-superfusion chambers (Hajos et al.
2009). For the cGMP immunohistochemistry experiments, slices were
transferred to sterile 12-well cell-culture plates (TPP). Each well was
ﬁlled with 1000 lL ACSF containing 1 mM 3-isobutyl-1-methylxanthine
(IBMX) and 100 lM BAY-73 6691 to block phosphodiesterase (PDE)
activity. Wells were individually bubbled with carbogen gas at equal
rates. Slices from 3 animals were divided into control- (CTRL-), sodium
nitroprusside- (SNP-), and oxadiazolo-quinoxaline-one (ODQ) + SNP-
wells. No drugs were applied in the control wells, 10 lM ODQ was
added to the ODQ + SNP-wells, and 30 min later 0.2 mM SNP was added
to the SNP- and ODQ + SNP-wells. After SNP administration, slices were
incubated for 10 more minutes. After incubation, the solutions were
quickly changed to ice-cold 4% paraformaldehyde in 0.1 M PB, and
then, the slices were postﬁxed in the same ﬁxative for 48 h at 4 C prior
to immunohistochemistry.
Immunohistochemistry
For immunogold and combined immunogold--immunoperoxidase stain-
ings, we incubated the sections in 1% human serum albumin (HSA;
Sigma) diluted in tris-buffered saline (TBS), pH 7.4. Then, the sections
were incubated for 60 h in the following solutions of primary
antibodies diluted in TBS: 1) rabbit anti-nNOS 1:5000, 2) 1:400 (Zymed
Laboratories, cat. no.: 61-7000), 3) rabbit anti-nNOS (1:400) combined
with mouse anti-GAD65 (1:1000, Millipore, cat. no.: MAB351), 4) rabbit
anti-NOsGC a1 (1:1000, Sigma-Aldrich, cat. no.: G4280) alone or
combined with mouse anti-GAD65 (1:250), or 5) rabbit anti-NOsGC b1
(1:2000, Cayman Chemical, cat. no.: 160897) alone or combined with
mouse anti-GAD65 (1:250). After repeated washes in TBS, sections
were treated with blocking solution (Gel-BS) containing 0.5% cold
water ﬁsh skin gelatin and 0.5% HSA in TBS for 1 h. This was followed by
incubation in the following solutions of secondary antibodies diluted in
Gel-BS for 24 h: 1) biotinylated donkey anti-rabbit (1:1000, Jackson
ImmunoResearch Europe Ltd), 2) 1.4-nm gold-conjugated goat anti-
rabbit (1:150, Fab’ fragment, Nanoprobes), 3) 1.4-nm gold-conjugated
goat anti-rabbit (1:150) combined with biotinylated donkey anti-mouse
(1:1000, Jackson ImmunoResearch Europe Ltd), or 4) and 5)
biotinylated donkey anti-rabbit (1:1000, Jackson ImmunoResearch
Europe Ltd) alone or combined with 1-nm gold-conjugated goat anti-
mouse (1:160, GE Healthcare). After intensive washes in TBS and 0.1 M
PB, sections were treated with 2% glutaraldehyde in 0.1 M PB for 15
min to ﬁx the gold particles into the tissue. In the combined method,
this was followed by further washes in 0.1 M PB, TBS, and incubation in
Elite ABC (1:300, Vector Laboratories) diluted in TBS. After this,
sections were washed in TBS and tris-buffer at pH 7.6. The
immunoperoxidase reaction was developed using 3,3-diaminobenzi-
dine (DAB) as chromogen. After repeated washes in TBS and
enhancement conditioning solution (Aurion), gold particles were
intensiﬁed using the silver enhancement solution (Aurion) for 25--60
min at room temperature. After subsequent washes, sections were
treated with 0.5% osmium tetroxide in PB for 20 min. Then, sections
were dehydrated in ascending ethanol series and acetonitrile and
embedded in epoxy resin (Durcupan, ACM, Fluka). During dehydration
sections were treated with 1% uranyl acetate in 70% ethanol for 20 min.
For the electron microscopic investigations, small resin-embedded
tissue samples were cut from the sections and glued onto plastic
blocks. After this, 70 and 90-nm thick sections were cut using a Leica
EM UC6 ultramicrotome and picked up on single-slot copper grids. The
sections were examined using a Hitachi H-7100 electron microscope
and a side-mounted Veleta CCD camera (Olympus Soft Imaging
Solutions).
For the double immunoﬂuorescent stainings, the slices were washed
in PB, embedded in agar, resectioned into 50 lm thick sections on
a Leica VT1000S Vibratome. After washes in PB and TBS containing
0.3% Triton X-100 (TBST; Sigma), sections were blocked for 45 min in
10% normal donkey serum (Vector Laboratories) dissolved in TBST.
After this, sections were incubated for 48 h in a mixture of the
following primary antibodies: sheep anti-cGMP (1:4000) and mouse
anti-GAD65 (1:250) diluted in TBS. This was followed by washes in TBS
and a 24 h incubation in biotinylated donkey anti-mouse (1:200) diluted
in TBS. After subsequent washes in TBS, sections were incubated for 24
h in the mixture of the following secondary antibodies: Alexa Flour 488
donkey anti-sheep (1:200) and Alexa Fluor 594 streptavidin (1:200)
diluted in TBS. This was followed by washes in TBS, PB, and the sections
were mounted onto glass slides, coverslipped with Aquamount (BDH
Chemicals Ltd). Immunoﬂuorescence was analyzed using an Olympus
Optical FluoView300 confocal laser scanning microscope in sequential
scanning mode.
Great care was taken to test the speciﬁcity of the antibodies used in
our work. The antibodies against nNOS was extensively tested before
(Szabadits et al. 2007), and we also repeated these control experiments
on ﬁxed brain tissue from nNOS–/– P6 animals, where staining could
not be observed. The antibodies, labeling the a1 and b1 subunits of
NOsGC were extensively tested earlier in our laboratory (Szabadits
et al. 2007), using colocalization and mRNA in situ hybridization
experiments. The anti-GAD65 antibody was also characterized and its
speciﬁcity was tested by other laboratories (Chang and Gottlieb 1988).
The speciﬁcity of the antibody against cGMP was also tested (de Vente
et al. 1987; Tanaka et al. 1997). Possible cross-reactions of secondary
antibodies were also tested in several control experiments that
conﬁrmed the speciﬁcity of these antibodies as well.
In Vitro Electrophysiology
Whole-cell recordings were performed at 31--32 C under visual
guidance using Zeiss Axioscope. ACSF, equilibrated with 5% CO2/95%
O2 gas, was superfused with the ﬂow rate of 2--3 mL/min. Patch
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solution containing in mM: 80 CsCl, 60 Cs-gluconate, 1 MgCl2, 2 Mg-
ATP, 3 NaCl, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 5
QX-314 (pH = 7.3, 290 mOsm). In some experiments, the pipette
solution contained 0.1--0.3% biocytin, and post hoc morphological
identiﬁcation of recorded cells using an immunoﬂuorescent method
conﬁrmed that these were all pyramidal neurons. PSCs were recorded
at a holding potential of –70 mV. Slices were superfused with ACSF
containing 2--3 mM kynurenic acid or 70--100 lM picrotoxin to block
ionotropic glutamate receptors or GABAA receptors, respectively. Using
a Supertech timer and isolator (Supertech Ltd, www.super-tech.eu),
electrical stimulation of ﬁbers was delivered in every 10 s (0.1 Hz) via
a theta glass pipette (Sutter Instrument Company) ﬁlled with ACSF. To
evoke glutamate receptor--mediated synaptic currents (GluR-PSCs) or
GABAA receptor--mediated PSCs (GABAAR-PSCs), the pipette was
placed in the stratum radiatum (str. rad.) or in the str. pyramidale,
respectively, in the CA1 region of the hippocampus. Access resistances
(between 4--15 MX, compensated 65--70%) were frequently monitored
and remained constant (±20%) during the period of recording. For
statistical analysis, the Wilcoxon matched pair (WMP) test or the Mann--
Whitney U test were used (OriginPro 8.0; OriginLab Corporation).
Multineuron Calcium Imaging
The recordings were performed at a ﬂow rate of 8--10 mL/min, at
32--33
oC. Areas from CA1 str. pyramidale were loaded with the cell-
permeant calcium indicator Fura-2 AM (20 lM) and pluronic acid
(0.16% w/v) in ACSF, using a standard patch pipette (2--4 lm diameter)
and a pressure microinjection system (Picospritzer, Narishige). Ratio-
metric imaging was performed using alternating excitation at 340 and
380-nm wavelengths with 100-ms exposure time, using a monochroma-
tor (TILL Photonics), while a CCD camera captured the emitted light
(TILL Photonics). Five hundred images were taken during 155 s with 4 3
4 pixel binning (1 ratiometric frame/310 ms). Relative changes in Ca
2+
levels were calculated from the ratio of the emitted ﬂuorescent light
in the 2 wavelengths (340 and 380 nm). Each active cell was marked
manually as a region of interest (ROI), and the changes in the ratio
during the measured periods were calculated in each ROI by the
software (TILL Photonics). Events were considered synchronous, if Ca
2+
signals increased simultaneously in more than 90% of the active cells.
In all examined slices, we compared the number of active versus
synchronous cells, and we found that at least 87% of the active cells
participated in the synchronous events (SEs). The number of active cells
recorded in one ﬁeld of view was 15 ± 5 standard deviation (SD). After
recording the control period, different drugs were bath applied to the
slices for 10--12 min (100 lM N-omega-Nitro-L-Arginine-Methyl-Esther-
Hydrochloride (L-NAME), 10 lMO D Q ,2 0 0lMS N P ,a n d5 0lMB r -
cGMP), followed by the second recording to monitor the effects of the
drugs on SEs. In every slice, we compared the number of SEs during the
control period and after drug application.
In some cases, the activities of single cells were recorded
simultaneously with the optical imaging of their Ca
2+ changes. In these
experiments, unit activity was recorded in loose patch mode, using
patch pipettes (3--6 MX) ﬁlled with ACSF. All data were recorded with
a Multiclamp 700B ampliﬁer (Axon Instruments), ﬁltered at 2 kHz,
digitized at 10 kHz, and analyzed off-line with the EVAN program
(courtesy of Prof. I. Mody, University of California, Los Angeles) and
Origin 8.0 (OriginLab Corporation).
Drugs
L-NAME, SNP, and 8-Br-cGMP were dissolved in distilled water; IBMX,
BAY-73 6691, and ODQ in dimethyl sulfoxide. Drugs were prepared as
stock solutions and diluted to the required concentrations. Drugs were
obtained from Tocris (www.tocris.com) or from Sigma (www.sigmaal-
drich.com).
Although SNP was reported to have some side effects under certain
conditions, its effect was always completely abolished by ODQ that is
a potent and highly selective inhibitor of the cGMP-producing NO
receptor (Garthwaite et al. 1995; Groneberg et al. 2008). In addition,
the effect of the cGMP analogue, that mimics the effect of NO, was
identical to the NO-donor SNP. Consequently, even if SNP had some
side effects, under the physiological conditions used in our experi-
ments they were undetectable, and the effects observed in our
functional assays are due to the effect of NO (released by SNP) via
the NO receptors.
Analysis
Because most data populations in this work did not have a Gaussian
distribution according to the Shapiro--Wilk’s W test, we used non-
parametric statistics. Two independent groups were compared using
the nonparametric Mann--Whitney U test; 2 dependent groups were
compared using the nonparametric WMP test; the null hypothesis was
rejected when the P level was under 0.05, and, in such cases, the
differences were considered signiﬁcant throughout this paper. In the
electron microscopic experiments, terminals were considered to be
GABAergic if they were GAD65 immunopositive, while terminals that
were GAD65 immunonegative and established asymmetric synapses
were considered to be glutamatergic. Indeed, post hoc analysis showed
that GABAergic terminals, selected on the basis of these criteria,
established signiﬁcantly larger synapses than glutamatergic terminals
(Mann--Whitney U test, P < 0.01). Furthermore, the postsynaptic
proﬁles of GABAergic terminals were larger than those postsynaptic to
glutamatergic boutons that is also expected because of the size
difference between dendritic shafts and spines.
Results
nNOS Is Associated with the Postsynaptic Active Zones of
GABAergic and Glutamatergic Synapses in the Developing
Hippocampus
Since synchronous neuronal activity is a characteristic phe-
nomenon of developing cortical networks that is most
prominent around postnatal day 6 in mice (Crepel et al.
2007; Alle ` ne et al. 2008), when GABAergic transmission is still
depolarizing, we focused most of our experiments to in-
vestigate this developmental stage. We localized nNOS during
these early postnatal days and performed single and double
immunogold--immunoperoxidase stainings for nNOS and
GAD65 on wild type (WT) and nNOS–/– mice. In the single
immunoreactions for nNOS in the P6 WT mice, the pyramidal
cells were stained weakly, and some strongly immunopositive
interneurons were detected in the CA1 and CA3 areas. In
nNOS–/– mice, no labeling was found. In the region of the
synaptic active zones, the immunogold-labeling pattern for
nNOS was identical in mice at P4 (Fig. 1E,F), P6 (Fig. 1A--C),
P10, and P14. Mostly postsynaptic densities were labeled in the
hippocampal CA1 and CA3 areas, with some labeling also
associated with extrasynaptic cell membranes, and a few gold
particles localized on intracellular membrane organelles close
to synapses. The linear density of the nNOS labeling was 1.36
gold particles/lm in the synapses (median, 0.7--1.37 min--max,
3 mice) and 0.06 gold particles/lm extrasynaptically (median,
0.06--0.07 min--max, 3 mice, Fig. 3E), while in the nNOS–/–
mice, no such labeling was detected. A remarkable 46% of
the fully reconstructed randomly sampled synapses from str.
rad. of CA1 of P6 mice were labeled for nNOS (median, 41--50%
min--max; n = 66 synapses in 3 mice, Fig. 3A).
Using GAD65 labeling and other morphological criteria (see
Materials and Methods), we identiﬁed GABAergic and gluta-
matergic terminals and found that postsynaptic nNOS immu-
nolabeling was present in both types of synapses in the CA1
and CA3 regions of P4 (Fig. 1E,F), P6 (Fig. 1B,C), P10, and P14
mice. We found that 40% of GABAergic (median, 27--47% min--
max; n = 45 synapses in 3 P6 mice) and 33% of glutamatergic
(median, 29--40% min-max; n = 44 synapses in 3 P6 mice) fully
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3B,C).
Both a1 and b1 Subunits of the NO receptor Are Present in
GABAergic Axon Terminals during Development
In order to examine the subcellular distribution of a1 and b1
subunits of NOsGC, we performed single and double stainings
for these subunits alone or in combination with GAD65.
The a1 subunit labeling of P4--P14 mice was similar to the
developmental labeling pattern described for GAD (Dupuy and
Houser 1996), suggesting that it labels mostly GABAergic
terminals. Unlike pyramidal cells in the CA1 and CA3 areas,
interneuron somata were a1 subunit immunopositive, along
with a dense meshwork of axonal ﬁbers and terminals localized
predominantly in the str. rad. at P4--P10. At P14 the labeling was
weaker but similar to the adult pattern (Szabadits et al. 2007),
that is, the cell bodies of interneurons were labeled in all layers
and their axon terminals were also a1 subunit positive,
especially in the str. pyramidale. In the adult hippocampus,
both in situ hybridization and immunohistochemical experi-
ments showed that the a1b1 subunit composition of the NO
receptor is interneuron speciﬁc (Szabadits et al. 2007), and
indeed, unlike pyramidal cells in the CA1 and CA3 areas,
interneuron somata were a1 subunit immunopositive at P4--
P10. In addition, we found that a1 subunit--positive terminals
always made symmetric synapses, and never asymmetric ones
nor did they contact spines or spine-like structures at any ages
examined. These data suggests that most if not all a1+ terminals
are GABAergic already during development, and indeed, in the
double-labeling experiments, we frequently found synaptic
terminals positive for both GAD65 and a1 subunits in the CA1
and CA3 regions at P4 (Fig. 1E,F), P6 (Fig. 1D), P10, and P14
ages. Fifty-four percent (median, 53--57% min--max; n = 88
synapses in 3 P6 mice) of the reconstructed, randomly sampled
GAD65-positive synaptic terminals in CA1 were positive for the
a1 subunit (Fig. 3D).
The b1 subunit labeling was similar to the adult pattern.
Pyramidal cells showed weak cytoplasmic staining, and the
neuropil showed a diffuse, punctate labeling. Interneuron
somata and immunopositive axon terminals were stained for
b1 subunit as early as P4--P6. The b1 subunit--containing axon
terminals formed symmetric synapses. In the double-immunos-
tained preparations, GAD65 and b1 subunit double-positive
axon terminals formed synapses in the str. rad. of CA1 and CA3
regions from P4, P6 (Fig. 1D), P10, and P14 mice.
These results show that the NOsGC a1b1 subunit compo-
sition is present in GABAergic terminals during postnatal
development, and it is in an ideal position to receive retrograde
NO signal synthesized in the postsynaptic compartment by
nNOS.
Activation of the NO Receptor Induces cGMP Production in
GABAergic Axon Terminals of the Developing
Hippocampus
To test whether the NO receptor is functional during the early
postnatal days, we prepared acute hippocampal slices from P6
Figure 1. The molecular elements of the retrograde NO-signaling pathway are present at GABAergic and glutamatergic synapses in the developing hippocampus at P4 and P6.
(A) Electron micrographs show immunogold labeling for nNOS in the postsynaptic active zones of dendritic synapses. (B) Two image series show postsynaptic nNOS immunogold
labeling in synapses made by GAD65-positive (dark DAB precipitate) axon terminals. (C) Electron micrographs show that nNOS is present postsynaptically in GABAergic synapses
on dendritic shafts and in glutamatergic synapses on spines in the CA1 and CA3 regions of the hippocampus. (D) Images show double immunohistochemical reactions for either
NOsGC a1o rb1 (dark DAB precipitate) combined with GAD65 (intensiﬁed gold particles). Both subunits of the NO receptor are present in GABAergic synaptic axon terminals in
the CA1 and CA3 areas. (E,F) The labeling patterns were identical in mice at P4 in the CA1 and CA3 areas (see above). (G) Photos demonstrate a complete lack of nNOS
immunolabeling in the knockout animals, in the nNOS-GAD65 double-labeling experiments. Scale bar is 200 nm for A and 300 nm for B--F. Black arrowheads point to the
intensiﬁed immunogold particles, white arrowheads show synapses. Spines (sp), dendrite shafts (d).
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inhibitors, and treated them either with no drugs, with the NO-
donor SNP (200 lM), or with a selective inhibitor of the NO
receptor (ODQ, 10 lM), followed by the addition of the NO
donor (Fig. 2A). These incubations were followed by ﬁxation
and double immunoﬂuorescent labeling for GAD65 and cGMP.
After incubation with no drugs (control conditions), we did not
ﬁnd labeled terminals in the randomly collected samples (Fig
2A—CTRL), but some glia-like cGMP immunoreactivity could
be detected in these control hippocampal slices. After NO-
donor (SNP) treatment, strongly cGMP-immunopositive ﬁbers
and terminals could be observed (Fig 2A—SNP) along with
a few labeled neuronal somata and some glia-like staining. After
pretreatment with ODQ, SNP could not induce any detectable
cGMP signal (Fig. 2A—ODQ + SNP). In the SNP-treated slices,
we found that 28% (median, 23--34% min--max; n = 508
terminals in 3 mice) of the randomly sampled GAD65-positive
terminals of the str. rad. showed cGMP immunoreactivity, and
at least 41% (median, 39--41% min--max; n = 335 terminals in
3P 6m i c e ,F i g .2 B) of the cGMP-positive terminals were positive
for GAD65 (Fig. 3F,G). Therefore, NOsGC is able to produce
cGMP in these terminals already during the ﬁrst postnatal days.
NO Decreases both GABAergic and Glutamatergic
Postsynaptic Currents in a NOsGC-Dependent Manner
Using a whole-cell patch-clamp method, we recorded evoked
PSCs in CA1 pyramidal cells in slice preparations from P5--P8
mice. First, we examined the effect of the NO donor, SNP
(200 lM) on the amplitude of pharmacologically isolated
GABAAR-PSCs, evoked by electrical stimulation in the str.
pyramidale. Application of SNP signiﬁcantly decreased the peak
amplitude of GABAAR-PSCs to 67% of control values (control
median amplitude: 186.5 pA and interquartile range: 149.2--
240.8 pA; median amplitude in SNP: 125.6 pA and interquartile
range: 92.8--184.8 pA, n = 12 slices, P = 0.00097, WMP test, Fig.
4A--C). The sensitivity of GABAAR-PSCs to SNP was not
homogenous. In the majority of cases, SNP reduced the
amplitude of events signiﬁcantly to 52% of control (control
median amplitude: 231.7 pA and interquartile range: 161.6--
443.9 pA; median amplitude in SNP: 120.3 pA and interquartile
range: 56.1--329.6 pA, n = 7 slices, P = 0.015, WMP test). In the
other cases, SNP caused no signiﬁcant change in the peak
amplitude (control median amplitude: 151.3 pA and interquar-
tile range: 142.7--180.9 pA; median amplitude in SNP: 137.6 pA
and interquartile range: 126.8---77.2 pA, n = 5 slices, P = 0.12,
WMP test). We then tested whether the suppressing effect was
mediated by NOsGC. We pretreated slices with ODQ, the
blocker of NOsGC, followed by coapplication of ODQ and SNP.
After the control period, we bath-applied 10 lM ODQ, which
caused a small reduction in the peak amplitudes of GABAAR-
PSCs (control median amplitude: 130.8 pA and interquartile
range. 92.8--226.2 pA; median amplitude in ODQ: 99.5 pA and
interquartile range: 50.2--171.8 pA, n = 9 slices, P = 0.004, WMP
test). Then, we treated the slices with SNP in the presence of
ODQ. In all but one instance, SNP could not reduce the
amplitude (median amplitude in ODQ: 132.3 pA and and
interquartile range: 63.3--194.2 pA; median amplitude in SNP +
ODQ: 131.8 pA and interquartile range: 56.7--181.4 pA, n = 8
slices, P = 0.25, WMP test, Fig. 4D--F). The comparison of the
control peak amplitudes of GABAAR-PSCs before application of
drugs in the 2 sets of experiments (SNP experiments [control:
186.5 pA] or ODQ + SNP experiments [control: 130.8 pA])
revealed no signiﬁcant difference (P = 0.18, Mann--Whitney U
test), suggesting that similar sets of GABAergic ﬁbers were
Figure 2. NO donor (SNP) induces cGMP production in a NO receptor--dependent manner in axon terminals during development. (A) Confocal laser scanning images show
immunoﬂuorescent cGMP labeling in the str. rad. of the hippocampus of P6 mice. In the presence of PDE inhibitors, slices were pretreated with: no drugs (CTRL), the NO-donor
SNP, or the NO-receptor blocker ODQ, followed by SNP (ODQ þ SNP). No terminals were labeled for cGMP in the randomly collected samples from the CTRL experiments (ﬁrst
column). SNP-induced cGMP production in the CA1 and CA3 areas (SNP, second column) was completely blocked by ODQ (ODQ þ SNP, third column). (B) Colocalization of
GAD65 and cGMP immunoreactivity in the NO donor--treated slices in the CA1 and CA3 areas (str. rad. of P6 mice). White arrowheads show some terminals that have cGMP and
GAD65 immunoreactivity. Scale bar: 5 lm for all images.
Cerebral Cortex September 2011, V 21 N 9 2069stimulated in both experiments. These results showed that NO
can control the efﬁcacy of GABAergic synaptic transmission via
activation of NOsGC.
Next, we investigated the impact of NO on glutamatergic
transmission as well. First, we tested the effect of SNP on the
peak amplitude of pharmacologically isolated ionotropic
GluR-PSCs evoked by focal stimulation in the str. rad.
Application of SNP invariably reduced the GluR-PSC ampli-
tude by half (control median amplitude: 63.2 pA and
interquartile range: 26.1--104.9 pA; median amplitude in
SNP: 30.58 pA and interquartile range: 9.1--60.5 pA, n = 7
slices, P = 0 . 0 1 5 ,W M Pt e s t ,F i g .5 A--C). Next, we pretreated
the slices with ODQ, which in itself did not alter signiﬁcantly
the peak amplitude (control median amplitude: 42.8 pA and
interquartile range: 24.3--120.6 pA; median amplitude in ODQ:
37.9 pA and interquartile range: 30.5--69.6 pA, n = 7s l i c e s ,P =
0.57, WMP test) but again occluded the effect of SNP (median
amplitude in SNP + ODQ: 31.1 pA and interquartile range:
25.2--70.1 pA, n = 7s l i c e s ,P = 0 . 2 2 ,W M Pt e s t ,F i g .5 D--F). The
control amplitudes of GluR-PSCs were similar in both sets of
experiments (P = 0.79, Mann--Whitney U test). These data
show that the glutamatergic synaptic communication is also
depressed by NO signaling via NOsGC in postnatal hippo-
campal slices.
Modulation of NO Signaling Alters Synchronous Network
Activity in Developing Hippocampal Slices
To test whether NO signaling can inﬂuence synapse-driven
synchronous network activity, we used multineuron calcium
imaging in acute hippocampal slices. Areas from CA1 str.
pyramidale were loaded with the calcium indicator Fura-2 AM
(20 lM, Fig. 6A). In control conditions, simultaneous calcium
imaging and recording of the unit activity of the same cell in
loose patch mode revealed that the calcium elevations
corresponded to burst ﬁrings of the same cells (Fig. 6B,C).
The number of SEs during recordings (155 s) was 8.6 ± 4.7 SD
(n = 26 slices).
Then, we examined the effect of pharmacological blockade
of the NO signaling on the occurrence of SEs. The NOS
inhibitor L-NAME (100 lM) signiﬁcantly increased the number
of SEs to 157% of control in WT (median, 145--700% min--max;
P = 0.0117, WMP test; n = 8 slices, in 4 mice, Fig. 6D,E) but not
in nNOS–/– mice (see Fig. 6E, n = 3, in 3 mice, open circles with
dashed lines). Similarly, the NO-receptor inhibitor ODQ (10
lM) also increased the number of SEs signiﬁcantly to 356.6% of
control (median, 178--583% min--max; P = 0.0277, WMP test; n
= 6, in 3 mice, Fig. 6F,G). These results indicated that there was
a basal NO signaling in the network that restrained the synapse-
driven SEs.
Stimulation of the NO-signaling pathway was also tested. We
bath applied either the NO-donor SNP (200 lM) or the
membrane-permeable cGMP-analogue Br-cGMP (50 lM). These
drugs signiﬁcantly decreased the number of SEs to 15.5% of the
control (median, 0--31% min-max; P = 0.0277, WMP test; n = 6,
in 4 mice, Fig. 6H,I) or to 41% of control (median, 17--60% min--
max; P = 0.0277, WMP test; n = 6, in 3 mice, Fig. 6J,K),
respectively. The effect of Br-cGMP could be completely
washed out in 4 of 6 slices (2 slices were not tested). Thus,
modulation of NO signaling can have a strong inﬂuence on
hippocampal synchronous activity in early stages of develop-
ment.
Discussion
Here, we investigated the NO signaling system in the mouse
hippocampus during the early postnatal days, when the ﬁrst
synapse-driven synchronous network activity occurs. Our
major ﬁndings are that 1) nNOS is present postsynaptically
both in GABAergic and in glutamatergic synapses, 2) both a1
and b1 subunits of the NO receptor are expressed in
Figure 3. Analysis of the distribution of NO-signaling molecules during postnatal development in 3 P6 mice (m1, m2, and m3). (A) The percentage of nNOS-positive synapses of
all identiﬁed synapses (n 5 66) from single-labeling experiments. (B,C) In double-labeling experiments, we also tested glutamatergic and GABAergic synapses separately. The
graphs show the percentages of nNOS-positive synapses of all glutamatergic synapses (B, n 5 44) and of all GAD65-positive synapses (C, n 5 45). (D) The percentage of
NOsGC a1-positive synapses of all GAD65-positive terminals (n 5 88). (E) The linear density of immunogold particles along the cell membrane for nNOS was 1.36 gold/lmi n
synapses (median, 0.7--1.37 min--max) and 0.06 gold/lm on extrasynaptic membranes (median, 0.06--0.07 min--max) tested on electron microscopic images (from 32 lm
synaptic and 604 lm extrasynaptic membrane segments). (F) The percentage of cGMP-positive terminals of all GAD65-positive terminals (n 5 508). (G) The percentage of
GAD65-positive terminals of all cGMP labeled terminals (n 5 335).
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can produce cGMP after NO stimulation, 4) NO signaling
reduces the amplitude of GABAergic and glutamatergic
synaptic currents, and 5) NO signaling is able to regulate
synchronous network activity.
Synapse-speciﬁc NO production during development
nNOS is activated by Ca
2+--calmodulin complex under con-
ditions of elevated intracellular Ca
2+concentrations (Prast and
Philippu 2001). In the mature brain, this elevation can be
generated by the activation of NMDA receptors at excitatory
synapses, and other mechanisms also exist at GABAergic
synapses (Makara et al. 2007; Szabadits et al. 2007). During
early postnatal development, depolarizing effects of GABA lead
to the activation of postsynaptic voltage--dependent calcium
channels around GABAergic synapses (Eilers et al. 2001;
Kullmann and Kandler 2008). This locally generated elevation
of Ca
2+ concentration may activate nNOS that we showed to be
present in these synapses.
NO can freely cross membranes and is detectable only a few
micrometers around its site of production (Namiki et al. 2005).
The concentration of NO remains effective up to a few
hundred nanometers away from the site of production
(Garthwaite 2008). Activation of NOsGC is highly effective
(Koesling et al. 2004), and deactivation is unexpectedly fast
(Bellamy et al. 2000). These properties suggest an effective
feedback pathway with a high spatial and temporal resolution.
Our results show that nNOS is enriched not only in
glutamatergic but also in GABAergic synapses, while the
functional NO receptor is present presynaptically. This
synapse-speciﬁc arrangement suggests that individual synapses
or a small subset of them can be differentially modulated by
retrograde NO signal.
NO signaling plays an important role in neuronal morpho-
genesis affects growth cones (Nikonenko et al. 2003), axonal
guidance (Murray et al. 2009), and NO promotes synapse
formation and stabilization as well (Nikonenko et al. 2008). In
addition, NO may also act via nitrosylating other proteins,
whereby it is able to modulate dendrite growth during
neuronal development (Zhang et al. 2010). We found that
nNOS was mostly localized in the postsynaptic densities of
different synapses; but the remaining labeling was mainly on
the cell membrane, from where it can diffuse to potential
presynaptic targets. Therefore, it seems that after NO
contributed to the establishment of functional synapses, the
complete signaling pathway is in place to modulate vesicle
release in GABAergic and glutamatergic synapses and to
regulate network activity efﬁciently.
NO-Induced Presynaptic cGMP Production in
Development
The NO-receptor NOsGC is present in the brain in 2 different
subunit compositions, as a1b1 and a2b1. In the adult
Figure 5. NO signaling suppresses glutamatergic synaptic transmission in the
developing hippocampus. (A--C) The NO donor SNP invariably reduced the peak
amplitude of ionotropic glutamate receptor--mediated synaptic currents compared
with control. On A,B, averaged events of 6--8 consecutive records were taken at the
labeled time points. (D--F) Slices were pretreated with the NOsGC blocker ODQ,
followed by coapplication of ODQ and SNP. ODQ abolished the effect of the NO donor.
On D,E, averaged events of 6--8 consecutive records were taken at the labeled time
points. For clarity, stimulus artifacts were removed from the averaged traces. C and F
show changes of peak amplitude in individual slices. (C,F) The vertical bars adjacent
to the pairwise comparisons indicate medians and interquartile ranges. The asterisk
indicates signiﬁcant difference (at P \ 0.05). Scale bars; A,D: 10 ms, 20 pA. B,E:
data shown as mean ± SEM.
Figure 4. NO signaling suppresses GABAergic synaptic transmission in the
developing hippocampus. (A--C) The NO donor SNP signiﬁcantly decreased the peak
amplitude of evoked GABAA receptor--mediated PSCs compared with control. On A,B,
averaged events of 6--8 consecutive records were taken at the labeled time points.
SNP either reduced the amplitude of events signiﬁcantly (sensitive, ﬁlled circles) or
caused no change in the peak amplitude (insensitive, empty circles). (D--F) Slices
were pretreated with the NOsGC blocker ODQ, followed by coapplication of ODQ and
SNP. ODQ abolished the effect of the NO donor. On D,E, averaged events of 6--8
consecutive records were taken at the labeled time points. For clarity, stimulus
artifacts were removed from the averaged traces. C and F show changes of peak
amplitude in individual slices. (C,F) The vertical bars adjacent to the pairwise
comparisons indicate medians and interquartile ranges of the corresponding data
(ﬁlled or empty symbols). The asterisk indicates signiﬁcant difference (at P \0.05).
Scale bars; A,D: 20 ms, 40 pA; B,E: data shown as mean ± standard error of the
mean (SEM).
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composition is restricted to principal cells (Szabadits et al.
2007). Similarly, we found a1 subunits only in interneurons,
while the b1 subunit was present also in pyramidal cells. We
found NO receptors in GABAergic terminals during develop-
ment. The lack of immunostaining for the b1 subunit in
glutamatergic terminals could be due to lower protein levels in
these smaller terminals or to the possible epitope masking of
the a2-containing receptors by speciﬁc anchoring proteins,
since these synapses could be also controlled by NOsGC
activity (present study).
The activation of NOsGC by NO leads to the formation of the
second messenger cGMP. Our results show that cGMP is
produced in GABAergic (GAD65 positive) terminals, and it is
mediated exclusively by the NO receptor because its inhibition
(by ODQ) diminished the cGMP signal. The incomplete overlap
between GAD65 and cGMP immunoreactivity suggests that
cGMP production may be present in glutamatergic terminals,
Figure 6. NO-signaling pathway can modulate the occurrence of SEs in acute hippocampal slices of 5--8 days old mice. (A) One representative frame of a movie, showing Fura-2
AM loaded pyramidal cells in the CA1 area. (B,C) Simultaneously recorded action potentials (lower trace) and ratiometric Ca
2þ signal (upper trace) of the same cell. Unit activity
was recorded extracellularly in a loose patch mode. The peaks in the ﬂuorescence signal corresponded to burst ﬁrings of the same neurons. Scale bars: 5 s for B, 0.5 s for C, 0.1
mA, and 110 F340/F380 for both. (D,F,H,J) SEs in acute hippocampal slices. Left panels show basal activities, right panels show activities after drug application in the same slice
preparation. The upper traces show the ratiometric Ca
2þ signals of a representative cell and the raster plots under the traces correspond to the Ca
2þ peaks of cells that
participated in SE. Each row represents one cell, before and after drug application. Scale bar in H applies for D,F, and J as well, the horizontal bar is 20 s, and the vertical bar is
100, 140, 140, and 250 F340/F380 for D,F,H and J, respectively. (E,G,I,K) Number of SEs per 155 s under control conditions and after drug application. The vertical bars adjacent
to the pairwise comparisons indicate medians and interquartile ranges of the corresponding data (ﬁlled or empty symbols). The asterisk indicates signiﬁcant difference (at P\
0.05). Note that the number of SEs changed in the same direction in each slice treated with the same drug. (D,E) The NOS inhibitor L-NAME elevated the number of SEs in the
WT (ﬁlled circles) but not in the nNOS /  mice (empty circles with dashed lines). (F,G) ODQ increased the number of SEs. (H--K) SNP and Br-cGMP reduced the number of SEs.
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cannot rule out the presence of some cGMP-containing
GABAergic terminals that were false immunonegative for
GAD65 due to technical reasons.
cGMP exerts its effects mainly via 3 molecular pathways, the
PDEs, cyclic nucleotide-gated ion channels (CNG channels),
and cGMP-dependent protein kinases (PKGs). In pyramidal
cells and interneurons, PDE 2 and 9 can be detected from P0,
while PDE 5 was found from P5 (Van Staveren et al. 2003). CNG
channel expression was detected before synapse formation
(Zufall et al. 1997), and there is a prominent expression of
PKGs, observed from embryonic day 13.5 (Demyanenko et al.
2005). These data show that neurons are well equipped to
process the NO-induced cGMP signal already during early
postnatal development.
Synaptic NO-Signaling Controls both Glutamatergic and
GABAergic Transmission and May Regulate
Developmental Network Activity
The activation of NO signaling can increase or decrease
transmitter release from different or even from the very same
terminals under different conditions (Garthwaite 2008). Similar
to our results, in the adult hippocampus, NO can act
presynaptically to reduce glutamate (Prast and Philippu 2001)
or GABA release (Makara et al. 2007). We showed that NO
signaling depressed both GABAergic and glutamatergic synap-
tic transmission during the early postnatal period in a NO
receptor--dependent manner. Because NO receptors were
found in presynaptic terminals, the reduction of the amplitude
of GABAergic synaptic currents is likely caused by the
modulation of presynaptic transmitter release. The distinct
NO sensitivity of different GABAergic connections found in the
present study could be due to activity-dependent dynamic
regulation of this signaling pathway, which may depend on the
level of maturation or the type of interneurons involved.
Synchronous network activity is a hallmark of developing
neuronal circuits (Ben-Ari et al. 2007; Blankenship and Feller
2010). The depolarizing GABAergic transmission is crucial for
the emergence of this pattern in rodents (Sipila et al. 2006),
primates (Khazipov et al. 2001), and in the human brain
(Dzhala et al. 2005; Vanhatalo et al. 2005). The temporally
patterned output of GABAergic interneurons and the intrinsic
bursting activity of pyramidal cells have also been shown to be
involved in the generation of synchronous network activities
during development (Sipila et al. 2005; Bonifazi et al. 2009).
Using multineuron calcium imaging, we investigated the
involvement of NO signaling in these activity patterns. We
propose that retrograde NO signaling may alter the efﬁciency
of transmission in a synapse-speciﬁc manner by modulating
GABAergic and glutamatergic synapses via the NOsGC--cGMP
pathway. Network synchrony in these animals is sustained by
a large population of neurons via synaptic connections (Crepel
et al. 2007; Bonifazi et al. 2009). Our results, showing that
synchronous network activity can be modulated in vitro by
exogenously applied blockers of the NO signaling pathway,
suggest that this signaling is active in a large number of
synapses during these SEs.
When synchronous burst activities depolarize pyramidal
cells, nNOS can be activated synaptically by raising Ca
2+
concentration, and NO receptor activation can become
maximal. This is mimicked by the application of the NO donor
or the cGMP analogue that in turn signiﬁcantly decreased the
number of SEs in our experiments. Our results also demon-
strated that the pharmacological blockade of the retrograde
NO-cGMP pathway at different stages signiﬁcantly elevated the
frequency of these SEs, indicating that under these physiolog-
ical conditions, there is a basal NO-signaling activity. This
suggests that NO signaling can restrain ongoing synchronous
activity, thus protecting the network from hyperactivity.
During the ﬁrst 2 postnatal weeks, feedback mechanisms are
needed to stabilize network activities produced by synchro-
nous discharges of large neuronal ensembles. Such mechanisms
may engage presynaptic GABAB autoreceptors, which have
been implicated in the control of SEs during development
(McLean et al. 1996). Endocannabinoid signaling represents
another system that can suppress release from a subset of
GABAergic interneurons but in this case, the effect depends on
postsynaptic activity and Ca
2+ transients (Bernard et al. 2005).
NO signaling is also retrograde, because it is triggered by
postsynaptic Ca
2+ transients and NO formation, but unlike
endocannabinoids, it is not restricted to synapses formed by
a particular subpopulation of interneurons. In addition, here we
described that it can affect both GABAergic and glutamatergic
signaling during development. Therefore, NO is ideally suited
to fulﬁll a general feedback role that modulates synchronous
network activity patterns during development.
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